Compile Data Set for Download or QSAR
Report error Found 88 Enz. Inhib. hit(s) with all data for entry = 7557
TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202376(US9238629, I-8 | US10081606, Compound I-8 | US9765...)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202379(US9238629, I-11 | US10081606, Compound I-11 | US97...)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202378(US9238629, I-10 | US10081606, Compound I-10 | US97...)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202373(US9238629, I-5 | US10081606, Compound I-5 | US9765...)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202371(US9238629, I-3 | US10081606, Compound I-3 | US9765...)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202380(US9238629, I-12 | US10081606, Compound I-12 | US97...)
Affinity DataIC50: 1nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202377(US9238629, I-9 | US10081606, Compound I-9 | US9765...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202389(US9238629, I-21 | US10081606, Compound I-21 | US97...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202372(US9238629, I-4 | US10081606, Compound I-4 | US9765...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202388(US9238629, I-20 | US10081606, Compound I-20 | US97...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202375(US9238629, I-7 | US10081606, Compound I-7 | US9765...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202390(US9238629, I-22 | US10081606, Compound I-22 | US97...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202369(US9238629, I-1 | US10081606, Compound I-1 | US9765...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202384(US9238629, I-16 | US10081606, Compound I-16 | US97...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202370(US9238629, I-2 | US10081606, Compound I-2 | US9765...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202381(US9238629, I-13 | US10081606, Compound I-13 | US97...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202383(US9238629, I-15 | US10081606, Compound I-15 | US97...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202374(US9238629, I-14 | US9238629, I-6 | US10081606, Com...)
Affinity DataIC50: 5.5nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [1-745,751-967](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202370(US9238629, I-2 | US10081606, Compound I-2 | US9765...)
Affinity DataEC50: <10nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [1-745,751-967](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202384(US9238629, I-16 | US10081606, Compound I-16 | US97...)
Affinity DataEC50: <10nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202379(US9238629, I-11 | US10081606, Compound I-11 | US97...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202391(US9238629, I-23 | US10081606, Compound I-23 | US97...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202374(US9238629, I-14 | US9238629, I-6 | US10081606, Com...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202375(US9238629, I-7 | US10081606, Compound I-7 | US9765...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202387(US9238629, I-19 | US10081606, Compound I-19 | US97...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202386(US9238629, I-18 | US10081606, Compound I-18 | US97...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202371(US9238629, I-3 | US10081606, Compound I-3 | US9765...)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202369(US9238629, I-1 | US10081606, Compound I-1 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202370(US9238629, I-2 | US10081606, Compound I-2 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [1-745,751-967](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202369(US9238629, I-1 | US10081606, Compound I-1 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202371(US9238629, I-3 | US10081606, Compound I-3 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202385(US9238629, I-17)
Affinity DataIC50: 55nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202377(US9238629, I-9 | US10081606, Compound I-9 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202378(US9238629, I-10 | US10081606, Compound I-10 | US97...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202379(US9238629, I-11 | US10081606, Compound I-11 | US97...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [1-745,751-967](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202371(US9238629, I-3 | US10081606, Compound I-3 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202373(US9238629, I-5 | US10081606, Compound I-5 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202374(US9238629, I-14 | US9238629, I-6 | US10081606, Com...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor [T790M,L858R](Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202375(US9238629, I-7 | US10081606, Compound I-7 | US9765...)
Affinity DataEC50:  55nMAssay Description:To assess phosphor-EGFR signaling, blots were probed with rabbit anti-Phospho-EGFR (Y1068) and mouse total anti-EGFR antibodies. Phospho-EGFR signal ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202381(US9238629, I-13 | US10081606, Compound I-13 | US97...)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202376(US9238629, I-8 | US10081606, Compound I-8 | US9765...)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202378(US9238629, I-10 | US10081606, Compound I-10 | US97...)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202372(US9238629, I-4 | US10081606, Compound I-4 | US9765...)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202388(US9238629, I-20 | US10081606, Compound I-20 | US97...)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202373(US9238629, I-5 | US10081606, Compound I-5 | US9765...)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202384(US9238629, I-16 | US10081606, Compound I-16 | US97...)
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202383(US9238629, I-15 | US10081606, Compound I-15 | US97...)
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202370(US9238629, I-2 | US10081606, Compound I-2 | US9765...)
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202369(US9238629, I-1 | US10081606, Compound I-1 | US9765...)
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Celgene Avilomics Research

US Patent
LigandPNGBDBM202377(US9238629, I-9 | US10081606, Compound I-9 | US9765...)
Affinity DataIC50: 200nMpH: 7.5 T: 2°CAssay Description:Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/21/2016
Entry Details
US Patent

Displayed 1 to 50 (of 88 total ) | Next | Last >>
Jump to: